OptimizeRx raises 2025 revenue guidance to $101M-$106M as subscription transition gains traction

Stock Information for OptimizeRx Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About OptimizeRx Corporation

OptimizeRx Continues Expansion of the Company's Point-Of-Care Network
OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance
OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET
OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference
OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising
OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth
OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.